Literature DB >> 12686087

The global agenda on influenza surveillance and control.

Klaus Stöhr1.   

Abstract

In collaboration with its many partners, WHO has developed a new Global Agenda on Influenza Surveillance and Control. The Global Agenda defines 17 priority activities that are critical to reducing the morbidity and mortality from annual influenza epidemics and preparing for the next pandemic. The Global Agenda will provide the foundation for global and national intervention plans, facilitate international coordination of prevention and control activities and contribute to renewed interest in epidemic influenza prevention and pandemic preparedness.

Mesh:

Year:  2003        PMID: 12686087     DOI: 10.1016/s0264-410x(03)00065-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Tackling the next influenza pandemic.

Authors:  Ran D Balicer; Michael Huerta; Itamar Grotto
Journal:  BMJ       Date:  2004-06-12

Review 2.  Global burden of influenza as a cause of cardiopulmonary morbidity and mortality.

Authors:  William A Fischer; Michelle Gong; Satish Bhagwanjee; Jonathan Sevransky
Journal:  Glob Heart       Date:  2014-10-31

3.  Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa.

Authors:  Richard Njouom; Serge A Sadeuh Mba; Dominique Noah Noah; Victoria Gregory; Patrick Collins; Pierre Cappy; Alan Hay; Dominique Rousset
Journal:  BMC Infect Dis       Date:  2010-03-08       Impact factor: 3.090

4.  Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance.

Authors:  Michael B Townsend; Erica D Dawson; Martin Mehlmann; James A Smagala; Daniela M Dankbar; Chad L Moore; Catherine B Smith; Nancy J Cox; Robert D Kuchta; Kathy L Rowlen
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 5.  Influenza vaccination in the elderly: impact on hospitalisation and mortality.

Authors:  Kristin L Nichol
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  MicroRNA-mediated species-specific attenuation of influenza A virus.

Authors:  Jasmine T Perez; Alissa M Pham; Maria H Lorini; Mark A Chua; John Steel; Benjamin R tenOever
Journal:  Nat Biotechnol       Date:  2009-05-31       Impact factor: 54.908

7.  Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics.

Authors:  Hiroichi Ozaki; Elena A Govorkova; Chenghong Li; Xiaoping Xiong; Robert G Webster; Richard J Webby
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection.

Authors:  Philippe Noriel Q Pascua; Min-Suk Song; Jun Han Lee; Kuk Jin Park; Hyeok-Il Kwon; Yun Hee Baek; Seung-Pyo Hong; Jong-Bok Rho; Chul-Joong Kim; Haryoung Poo; Thomas S Ryoo; Moon-Hee Sung; Young Ki Choi
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

9.  Quantifying pathogen surveillance using temporal genomic data.

Authors:  Joseph M Chan; Raul Rabadan
Journal:  MBio       Date:  2013-01-29       Impact factor: 7.867

10.  Molecular surveillance of low pathogenic avian influenza viruses in wild birds across the United States: inferences from the hemagglutinin gene.

Authors:  Antoinette J Piaggio; Susan A Shriner; Kaci K VanDalen; Alan B Franklin; Theodore D Anderson; Sergios-Orestis Kolokotronis
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.